ImunofanИмунофан
What is it?
A synthetic RDKVYR hexapeptide with laboratory immune and tissue-repair research. Historical Thymohexin nomenclature contains conflicting sequence order.
Research context
A synthetic RDKVYR hexapeptide with laboratory immune and tissue-repair research. Historical Thymohexin nomenclature contains conflicting sequence order.
What the studies found
animal · 2020
Human skin-cell cultures and mice
RDKVYR increased proliferation in cultured skin cells and modestly improved ear-pinna repair in mice. The paper calls it Imunofan/Thymohexin; older RKDVYR records must not be silently merged with this sequence.
Limit: Preclinical study, not a human wound-healing trial.
Imunofan-RDKVYR Peptide-Stimulates Skin Cell Proliferation and Promotes Tissue Repair. ↗Selected findings, not a systematic review or a treatment recommendation. Combination and related-preparation results cannot be attributed to this compound alone. See each source for access status and remaining limitations.
- Working classification
- Peptide research family
- Research collection
- Peptide bioregulation · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —No human treatment trial assessed for this family
- Study methods
- —Member-specific studies; patents and archival leads identified separately
- Independent replication
- —Independent replication not established by the records collected here
- Source access
- —Primary abstracts, selected full texts, patents and explicit retrieval targets
- Safety evidence
- —Cell and animal effects do not establish human safety; analogues may differ
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Inside this research family
Grouping supports navigation. It does not imply equivalent composition, mechanisms, effectiveness or safety.
| Member | Identity | What the source supports |
|---|---|---|
| Imunofan | RDKVYR | The 2020 study tested skin-cell responses and mouse ear repair. Imunofan-RDKVYR Peptide-Stimulates Skin Cell Proliferation and Promotes Tissue Repair. ↗ |
| Historical Thymohexin | RKDVYR in an earlier indexed report | Asp/Lys order differs. Related naming is not sufficient to transfer results between preparations. Imunofan-RDKVYR Peptide-Stimulates Skin Cell Proliferation and Promotes Tissue Repair. ↗ |
Interpretation and open questions
The preparation tested in each paper takes precedence over a shared or historical product name.
Linked sources
Explore the research map and unresolved leads ↗
Imunofan-RDKVYR Peptide-Stimulates Skin Cell Proliferation and Promotes Tissue Repair.
Sawicka J, Dzierżyńska M, Wardowska A, Deptuła M, Rogujski P, Sosnowski P, Filipowicz N, Mieczkowska A, Sass P, Pawlik A, Hać A, Schumacher A, Gucwa M, Karska N, Kamińska J, Płatek R, Mazuryk J, Zieliński J, Kondej K, Młynarz P, Mucha P, Skowron P, Janus Ł, Herman-Antosiewicz A, Sachadyn P, Czupryn A, Piotrowski A, Pikuła M, Rodziewicz-Motowidło S · Molecules (Basel, Switzerland)
RDKVYR increased proliferation in cultured skin cells and modestly improved ear-pinna repair in mice. The paper calls it Imunofan/Thymohexin; older RKDVYR records must not be silently merged with this sequence.
- Population / setting
- Human skin-cell cultures and mice
- What was checked
- Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Limitations & review scope
- Preclinical study, not a human wound-healing trial.
- RDKVYR differs from the RKDVYR spelling in older Thymohexin literature; preparation equivalence is unresolved.
Source checked 2026-10-05. This is a source-linked record, not a completed evidence review.